2nd announcement.
Smart to pay their money otherwise they could miss out on all the booty!!
181108 Central Petroleum Limited (Central-ASX ticker CTP) Petroleum Exploration Australia Limited (PXA) Joint Venture
Central is pleased to announce that PXA has paid to Central, as Operator, $4,849,464.36, representing outstanding cash calls previously made (plus related interest) relevant to the broadacre Joint Venture between Central and various subsidiary Companies and PXA.
The granted permits involved in the broadacre Joint Venture to date are EP 82, 93, 105,106, 107, 112, 115,118 and 125.
Central as Operator of the Joint Venture has recommended to the Joint Venture partners (unless otherwise agreed), to further suspend drilling and or seismic field operations at least until the end of the Northern Territory wet season. In the interim, decisions regarding continuance or modification of the current suspended programme will be made.
- Forums
- ASX - By Stock
- discovery
CTP
central petroleum limited
Add to My Watchlist
0.00%
!
5.4¢

2nd announcement.Smart to pay their money otherwise they could...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.24M |
Open | High | Low | Value | Volume |
5.4¢ | 5.7¢ | 5.4¢ | $110.6K | 2.011M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15150 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15150 | 0.054 |
1 | 94708 | 0.053 |
4 | 684063 | 0.052 |
2 | 820000 | 0.051 |
3 | 500000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 15000 | 1 |
0.058 | 6030 | 1 |
0.059 | 326120 | 2 |
0.060 | 160000 | 3 |
0.061 | 100000 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
CTP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online